the perioperative management of patients with musculoskeletal disease and for the burns patient
TRANSCRIPT
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
The perioperativemanagement of patients withmusculoskeletal disease andfor the burns patientPeter Berry
Patricia Richardson
AbstractMusculoskeletal disease may exist as a single or multi-system disorder
and affects patients in all age groups. Pre-anaesthetic assessment should
be focussed on defining the extent of both musculoskeletal disease and
systemic disease, and consideration will need to be given to the manage-
ment of medications in the perioperative period. Limited joint mobility
can hinder dynamic preoperative assessment of cardiorespiratory reserve.
The range of neck movement will influence the choice of anaesthetic tech-
nique and this should be planned well in advance of surgery. The need for
postoperative high dependency or intensive care should be anticipated.
Patients with burns present many potential problems in both the acute
and longer term. Protecting the airway from rapid swelling is an urgent
priority in the acute phase. Large burn injuries cause systemic changes
in fluid balance, temperature control and metabolic rate. Long-term
changes in physiology, pharmacokinetics and mental state need to be
considered when planning perioperative care.
Keywords Anaesthesia; ankylosing spondylitis; burn injury; malignant
hyperpyrexia; muscular dystrophy; musculoskeletal disease; rheumatoid
arthritis
ANAESTHESIA IN PATIENTS WITH MUSCULOSKELETAL DISEASE
Musculoskeletal diseases (MSDs) comprise a wide range of
multi-system disorders that affect all age groups. Whilst some are
very common and others thankfully rare, all are chronic. Patients
affected by these diseases may present either for incidental
surgery or for procedures related to their condition.
Preoperative assessment
The goals of assessment are to assess the likely impact of surgery
and anaesthesia on the patient, and the impact of the patient’s
disease and functional status on the conduct of surgery and
anaesthesia. The elderly, paediatric patients, and patients with
Peter Berry BMed Sci BM BS FRCA is a Fellow in Burns and Plastics
Anaesthesia at St Andrew’s Centre for Plastic Surgery and Burns,
Broomfield Hospital, Essex, UK. Conflicts of interest: none declared.
Patricia Richardson BM MRCP FRCA is a Consultant Anaesthetist at
St Andrew’s Centre for Plastic Surgery and Burns, Broomfield Hospital,
Essex, UK. Conflicts of interest: none declared.
SURGERY 28:9 452
significant comorbidities require additional attention. In many
instances, patients will already have undergone multiple proce-
dures and reviewing the records of previous anaesthetics and
asking directly about problems or preferences will be of benefit.
Poor exercise tolerance is an important predictor of perioper-
ative respiratory and cardiovascular complications. Limited joint
mobility can ‘protect’ patients from symptoms such as angina that
are induced or exacerbated by exercise. Consequently the use of
activity-based cardiorespiratory testing with a treadmill or cycle
ergometer (as in cardiopulmonary exercise, CPEX) will be diffi-
cult. An arm-cycle ergometer, thallium scintigraphy or dobut-
amine stress echocardiography are useful alternatives. Circulating
levels of B natriuretic peptide (BNP)may also be used to assess the
risk of perioperative cardiac events; >300 pg/ml signifies a high
risk whilst <100 pg/ml signifies a low risk.
Assessment of the upper airway is essential when planning
perioperative airway control (see below). Direct laryngoscopy
requires goodmouth opening and the ability to flex the neck while
extending the atlanto-occipital joint. Rheumatoid arthritis may
cause atlanto-axial subluxation, and temporo-mandibular joint
involvement may limit mouth opening. As only 25% of patients
with cervical spine instability have neurological symptoms it is
prudent to assess neck mobility and associated symptoms in the
patient awake, and determine the degree of mechanical instability
with cervical spine radiographs taken in flexion and extension.
Ankylosing spondylosis fuses the spine, reducing neck movement
and rendering tracheal intubation under direct vision extremely
difficult. Congenital (achondroplasia) or acquired (acromegaly,
facial trauma) deformities of the facial bones can also lead to
difficulty with mask ventilation and intubation.
Therapy with disease-modifying drugs will require special
consideration in the perioperative period. Anti-rheumatic drugs such
as gold, penicillamine and corticosteroids can be toxic to the kidneys,
bonemarrowor immunesystem.The risksof reducedwoundhealing
and infection need to be balanced against the risks of stopping
therapy. Corticosteroids must not be stopped abruptly and in those
patientswhohave taken>10mg/dayprednisolone (or equivalent) in
the preceding 3 months, intravenous supplementation will be
required for up to 72 hours because of adrenal suppression. Further
guidance can be found in the British National Formulary.
Many MSDs have a multi-system component and preoperative
assessment should involve questioning to determine the extent of
disease. Boxes 1e3 summarize clinical characteristics of some of
the most frequently encountered diseases and malignant hyper-
pyrexia. This latter, inherited disorder is rare, but patients may
show a fatal response to anaesthetic agents.
Intraoperative management
Airway control
The most appropriate method of achieving safe airway control is
usually dictated by the surgical procedure proposed, patient
positioning and individual patient risk factors. The laryngeal
mask airway (LMA) can usually be inserted with less mouth
opening and neck movement than is required for tracheal intu-
bation, but does not fully protect the airway from aspiration or
allow ventilation with high airway pressures.
Nasal or oral fibreoptic tracheal intubation is considered the
safest means by which to secure the airway when direct
� 2010 Elsevier Ltd. All rights reserved.
Anaesthetic implications of musculoskeletal diseases
Rheumatoid arthritis
C Multi-system disease affecting up to 3% of females and 1% of
males associated with
Temporomandibular joint disease reducing mouth opening.
Atlanto-axial subluxation which may be asymptomatic.
Excessive neck movement which risks cervical cord
compression.
Pulmonary fibrosis causing restrictive changes.
Pleural effusion and pulmonary nodules.
Pericardial effusion (usually asymptomatic), rarely
pericarditis, myocarditis and conduction defects.
Vasculitis effective vessels of any size.
Anaemia, usually normochromic anaemia of chronic
disease.
Secondary anaemia from drug-induced myelosuppression
or occult bleeding with non-steroidal anti-inflammatory
drug (NSAID) use.
Renal impairment; interstitial nephritis, amyloid or drug-
induced.
Peripheral neuropathy due to entrapment (cervical nerves,
ulna nerve at the elbow, etc.) or vasculitis.
C Full blood count, creatinine and electrolytes, electrocardio-
graphy (ECG), chest radiograph necessary for every case.
C Consider cervical spine radiographs, pulmonary function tests
and echocardiography depending on signs and symptoms.
Ankylosing spondylitis
C Kyphosis and fusion of the spine can make intubation difficult
or impossible without fibreoptic techniques.
C Difficult patient positioning and access for central neuraxial
block.
C Pulmonary fibrosis and limited chest expansion can compro-
mise gas exchange.
C Cardiomegaly, aortic regurgitation may be present, rarely
conduction defects.
C Renal impairment, may be due to amyloid.
ScoliosisC Chest deformity causes limited expansion and restrictive defect.
C Plan for postoperative ventilation if vital capacity <50%
predicted.
C Chronichypoxia causespulmonaryhypertension, right ventricular
hypertrophy and consequent failure (cor pulmonale).
C Assess with ECG, echocardiography and pulmonary function
tests.
Box 1
Anaesthetic implications of specific diseases
Myaesthenia gravis
C Autoimmunediseaseof the postsynaptic acetylcholine receptor.
C Muscle weakness causes reduced respiratory reserve, aspira-
tion risk and sensitivity to neuromuscular blocking (NMB)drugs.
C Preoperatively, optimize medical treatment and ask about the
effects of a missed dose.
C Maintain normal anticholinesterase treatment up to time of
induction and restart as soon as possible postoperatively.
C Pulmonary function tests help predict the need for post
operative ventilation.
Dystrophia myotonica
C A group of hereditary degenerative diseases causing persis-
tent contraction of skeletal muscle following stimulation,
progressing to muscle atrophy.
C Muscle contraction is unaffected by regional anaesthesia and
most NMB drugs, but suxamethonium should be avoided.
C Bulbar palsy and reduced gastric emptying cause an aspiration
risk.
C Deterioration of skeletal, cardiac and smooth muscle causes
deterioration in cardiorespiratory function and cardiomyopathy.
C Endocrine dysfunction, central respiratory depression, mental
deterioration, cardiac dysrhythmias and mitral valve prolapse
may occur.
C Postoperatively avoid or minimize opiates. High-dependency
care is essential.
Muscular dystrophy
C A group of hereditary diseases causing atrophy in affected
muscle groups.
C Risk of aspiration due to reduced gut motility and weak
laryngeal reflexes.
C Respiratory muscle weakness causing restrictive defect and
poor cough.
C Heart failure due to myocardial degeneration e avoid cardiac
depressing drugs.
C Kyphoscoliosis due to muscle weakness.
C Avoid suxamethonium and reduce dose of other NMB drugs.
C Postoperatively avoid or minimize opiates. High-dependency
care is essential.
Box 2
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
laryngoscopy and tracheal intubation are expected to be very
difficult. This can be done ‘awake’ using topical local anaes-
thesia, before the induction of general anaesthesia.
Ventilation
Some MSDs are associated with respiratory complications that
must be considered when deciding upon an anaesthetic tech-
nique. Restrictive pulmonary disease may be the result of lung
SURGERY 28:9 453
fibrosis (as in rheumatoid arthritis) or a skeletal deformity (as
in scoliosis). Muscle disorders (e.g. muscular dystrophy)
resulting in respiratory muscle weakness can cause respiratory
failure and impair the ability to cough effectively. In some
cases mechanical ventilation is the most appropriate technique,
in other cases spontaneous ventilation or avoiding general
anaesthesia by use of regional or local anaesthesia may be
safer.
Positioning
Safe positioning is the responsibility of both the surgeon and the
anaesthetist. Osteogenesis imperfecta leads to easy fracturing,
� 2010 Elsevier Ltd. All rights reserved.
Malignant hyperthermia (MH)
Potentially fatal disorder of skeletal muscle that presents
during general anaesthesia.
Incidence of 1:10,000 of the population, all races are affected.
Autosomal dominant inheritance but several different
mutations identified.
Mortality has dropped to 2e3% with improved awareness and
treatment.
Caused by a loss of normal Ca2þ homeostasis at some point
along the system of excitationecontraction coupling.
Presentation
Triggered by suxamethonium (succinylcholine) and/or volatile
anaesthetics. Local anaesthetics and intravenous anaesthetics
are thought to be safe.
Most patients have one or more uneventful general
anaesthetics before the one that causes the crisis. The reason
for this is unknown.
Clinical signs are divided into two groups
C Uncontrolled muscle contraction: rigidity, masseter spasm,
hyperkalaemia, high creatine kinase, myoglobinuria.
C Metabolic storm: tachycardia, pyrexia, increased CO2 produc-
tion, metabolic acidosis.
Management
Remove triggers and convert to alternative anaesthetic tech-
nique (e.g. total intravenous anaesthesia).
Hyperventilate with 100% O2.
Stop surgery if feasible or call for extra surgical help to
conclude operation as quickly as possible.
Administer intravenous dantrolene (1e10 mg/kg) and cool
patient with ice packs and cold water lavage.
Watch for hyperkalaemia, acidosis, coagulopathy, myoglobi-
nuria and acute renal failure. Manage on intensive care unit.
Box 3
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
and the hypermobile joints associated with some collagen
disorders (e.g. Marfan’s syndrome) may become dislocated.
Corticosteroid use is associated with skin thinning and osteopo-
rosis. Rheumatoid arthritis may cause instability of the cervical
spine. Preoperative assessment should include a review of which
joint positions are most comfortable. Inflamed and painful joints
must be carefully padded and excessive pressure on small areas
avoided.
Venous access
Patients with MSD may have undergone multiple procedures
resulting in scarring and thrombosis of peripheral veins. Venous
cannulation may be made more difficult by limb deformity or
proximity to surgical site. Care must be taken when securing
intravenous cannulae to prevent pressure necrosis and skin
damage secondary to the inappropriate use of adhesive dressings.
Anaesthetic technique
Despite its attendant risks, general anaesthesia may be the
preferred option when surgery is likely to be prolonged,
SURGERY 28:9 454
significant blood loss is anticipated or the surgical site precludes
a regional technique. The residual effects of anaesthetic drugs on
respiratory function in patients with muscular disease dictate
that high-dependency or intensive care facilities may be needed
postoperatively.
A number of anaesthetic drugs require careful consideration
in specific patient groups. The depolarizing neuromuscular
blocker suxamethonium causes rapid hyperkalaemia in patients
with spinal cord injury and muscular dystrophies. In patients
with myotonia it may produce muscle rigidity and interfere with
airway control. Care must also be taken with non-depolarizing
neuromuscular blockers as their effect can be unpredictable in
patients with muscular disease.
Central neuraxial (spinal or epidural) anaesthesia has the
advantage of having minimal impact on the respiratory muscles,
where the block remains below T10, and obviates the need for
tracheal intubation (and thus neck movement). This is therefore
often the anaesthetic technique of choice for lower limb surgery.
However, accessing the subarachnoid (spinal anaesthetic) or
epidural space may be difficult in patients with spinal immobility
or following spinal surgery. Furthermore, in conditions such as
scoliosis, local anaesthetic spread is unpredictable. Blockade of
the sympathetic nerves causes widespread vasodilation, reducing
both venous return (preload) and systemic vascular resistance
(afterload) e changes that may be catastrophic in patients with
cardiac disease. In patients receiving low-molecular-weight
heparin insertion or removal of an epidural catheter, and lumbar
puncture (subarachnoid block) should be delayed until 12 hours
after the last dose, and a subsequent dose should not be given for
at least 6 hours.
Regional anaesthetic techniques, either as a conventional
‘single-shot’ block or a catheter technique to prolong the effect,
may be useful for operations involving a single limb. Used alone,
they avoid the systemic effects of general anaesthesia. When
used as an adjunct to general anaesthesia they reduce perioper-
ative opiate requirements, which is of particular benefit in those
with limited respiratory reserve.
Postoperative care
High-dependency and intensive care
When managing patients with complex multi-system diseases
preoperative planning should include identification of the most
appropriate setting for postoperative care. Patients with muscular
disease must be monitored in a high-dependency area for signs of
respiratory failure (rising respiratory rate and pCO2, falling tidal
volume and vital capacity), but in some cases a period of elective
postoperative mechanical ventilation may be appropriate.
Patients with poor respiratory function should have preoperative
multi-disciplinary review, so that risks can be discussed, the
patient can give fully informed consent and appropriate post-
operative care can be planned.
Analgesia
Pain relief can present a challenge in patients who are already
habituated to analgesics. Where possible, it is prudent to seek the
advice of the acute pain team. The general principle is to
continue any pre-existing analgesics and add further agents to
cover the perioperative period. Opiates, administered using
patient-controlled analgesia (PCA) systems, may be combined
� 2010 Elsevier Ltd. All rights reserved.
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
with ‘chronic’ oral opiates in this way. However, most PCA
systems require the patient to push a button; this may be difficult
or impossible for those with a hand deformity (e.g. rheumatoid
arthritis) or bandaging. Opiates should be avoided in patients
suffering from muscular disorders who are at risk of respiratory
depression. Local anaesthetics infused via epidural or nerve
plexus catheters may be particularly useful in these
circumstances.
Physiotherapy and mobilization
Physiotherapy will be essential for many patients both to assist
with joint mobilization and to reduce the risks of venous
thromboembolism and respiratory complications. Analgesia
needs to be adequate to cover physiotherapy and movement, not
just pain at rest.
ANAESTHESIA IN THE ACUTE BURNS PATIENT
Patients suffering a significant thermal injury should be trans-
ferred to a specialist burns unit. Surgical management will be
required in the early phase for deeper burns as wound debride-
ment and skin grafting allow faster wound closure than conser-
vative, non-surgical management. Ongoing operative procedures
may be necessary for scar revision and contracture release but
burns patients may also present to a non-specialist centre for
other types surgery and it is important to understand the unique
needs of these patients.
Airway and respiratory system
Following a burn injury, early tracheal intubation should be
considered in patients at risk of airway obstruction e those with
facial burns, singed nasal hair, carbonaceous sputum or
hoarseness. The endotracheal tube should be left uncut in case
facial swelling worsens. Circumferential chest burns may restrict
chest wall movement and escharotomies will be needed to enable
adequate ventilation.
Smoke contains a cocktail of noxious chemicals, which cause
inhalational chemical burns, in addition to the chemical
asphyxiants carbon monoxide and cyanide. Fibreoptic bron-
choscopy can identify the extent of injury and facilitate lavage of
inhaled soot. Smoke inhalation is not an indication of tracheal
intubation per se, but subsequent inflammation may lead to acute
respiratory distress syndrome (ARDS).
Resolution of the acute inflammatory changes occurs with
varying degrees of fibrotic scarring and long-term respiratory
disability may be significant. As the burn wound heals, neck
scarring and contractures may limit head and neck movement,
making tracheal intubation difficult; fibreoptic intubation can
enable safe control of the airway in this situation.
Circulatory changes and fluid balance
Major burn injuries result in rapid activation of a systemic
inflammatory response and widespread capillary leak in both
burnt and unburnt tissue. Large quantities of fluid will be
required in the early stages of resuscitation in order to maintain
tissue perfusion. Hypovolaemia and myoglobin release from
damaged muscle put the kidneys at risk of acute tubular necrosis.
Haemodynamic monitoring in the first 48 hours, or resuscitative
phase, typically reveals a picture of myocardial depression and
vasoconstriction, evolving in to one of widespread vasodilatation
SURGERY 28:9 455
and increased cardiac output in the second, post-48-hour
hyperdynamic phase.
Burn excision and harvesting of donor skin for grafting have
the potential for significant blood loss and massive quantities of
blood and clotting factors are frequently required. Older and
infected burns tend to bleed more profusely. Accurate measure-
ment of blood loss is difficult and measurement of haemoglobin
concentration and coagulation tests should be used to guide
transfusion requirements.
Microvascular changes following burn injury result in loss of
intravascular water, sodium and albumin. Ongoing electrolyte
imbalance will impact upon choice of fluid replacement and
handling of infused free water. Both invasive (e.g. pulmonary
artery catheter) and non-invasive (e.g. oesophageal Doppler
monitor) haemodynamic monitoring are routinely used to assess
volaemic status and the response to fluid administration.
Hypermetabolic response
A major burn injury is followed by a marked hypermetabolic
response; the normal basal metabolic rate of 35e40 kcal/body
surface area/hour is increased by 50% following 25% burn and
doubled where burn injury exceeds 40% burn surface area. The
development of sepsis will increase this further. Catabolism, with
nitrogen loss and lipolysis must be matched with an increased
calorie intake to prevent excessive weight loss, and periods of
starvation prior to anaesthesia must be kept to a minimum.
Nasogastric feeding may be administered overnight and intu-
bated patients may be fed in this way during surgery. Increased
calorie requirements will persist for at least a year following burn
wound closure.
Although the hypothalamic core temperature ‘set point’ is
increased by 0.03 �C for each 1% of body surface area burned, loss
of cutaneous mechanisms reduces the ability to regulate body
temperature. Loss of thermoregulation persists indefinitely in
areas of skin grafting. Thermoregulation is further impeded during
both regional and general anaesthesia, and every effort must be
made to maintain body temperature. Overhead heaters, the use of
warmed fluids for infusion and irrigation, and a high ambient
temperature and humidity are all necessary to avoid hypothermia
which, unchecked, would increase calorie requirements further.
Pharmacological changes
A reduced serum albumin concentration will increase the
unbound fraction of acidic drugs (e.g. anticonvulsants, sulpho-
nylureas) and increased a1-acid glycoprotein concentration
reduces the unbound fraction of basic drugs (e.g. local anaes-
thetics, propranolol, muscle relaxants). The increase in total
body water alters drug compartment sizes and the hypermeta-
bolic state will further alter pharmacokinetics of some drugs.
These changes may persist for months.
Muscle relaxant use is of particular interest in this patient
group. The long-acting non-depolarizing muscle relaxants have
a significantly reduced duration of action in the hypermetabolic
burn patient. Suxamethonium is a short-acting depolarizing
muscle relaxant used to assist in tracheal intubation, in particular
where difficulty is anticipated. It precipitates a marked hyper-
kalaemic response in burns patients from 2 to 3 days after injury.
The risk persists for about a year and the drug is best avoided
altogether in this population.
� 2010 Elsevier Ltd. All rights reserved.
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
Burn patients develop a tolerance to opiates that cannot be
entirely explained by the defined metabolic changes outlined
above and frequently need massive doses for analgesic effect.
Opiate switching, for example to methadone, has been used with
some success. There is evidence to suggest that N-methyl-D-
aspartate (NMDA) receptor blockade, an effect demonstrated by
methadone, may attenuate this effect. Ketamine and gabapentin
are other useful drugs in this respect.
Other perioperative factors
Minimum monitoring for any patient under anaesthesia is rec-
ommended as including electrocardiography (ECG), blood pres-
sure, pulse oximetry, and respiratory gas analysis. This may be
difficult to achieve in a patient with a burnt chest and injured
limbs. The ECG may be obtained using fetal scalp electrodes that
hook into the chest wall and blood pressure can be measured
invasively. Pulse oximeter use can be impossible and the
anaesthetist may need to rely on blood gas analysis.
As a general rule, intravascular lines should not be inserted
through burnt tissue although avoidance may not be possible.
They are best sutured in as adhesives are unreliable on injured
skin, and frequent turning of patients will increase the risk of
inadvertent line removal.
Patient identification bands may be difficult to secure and
labelling of a ‘fixed’ piece of equipment, such as the urinary
catheter, with patient details aids positive identification prior to
procedures and blood transfusions.
Postoperative considerations
The debridement of wounds and harvesting of skin grafts induce
a considerable, additional stress response. Careful consideration
must be given to whether the patient would be best managed in
a high-dependency area postoperatively. In particular, following
facial surgery, when swelling may recur and a period of artificial
ventilation may be necessary.
SURGERY 28:9 456
Reorganization of the burn wound and nerve regeneration
means that analgesic requirements change throughout the
duration of healing for better and for worse. Following burn
wound debridement nociceptive neuronal traffic from the wound
will alter. Sites of donor skin harvest are notoriously painful.
Burns patients require a dynamic analgesic regime able to cope
with these variations. This is impossible without effective, timely
pain scoring which must be appropriate to the patient’s age and
their social and ethnic background. Paracetamol is opiate
sparing, has very few contraindications and should be consid-
ered in all patients. The non-steroidal anti-inflammatory drugs
are effective for the inflammatory nature of burn pain, yet are
contraindicated in the acute setting and following major burns
because of the increased incidence of renal complications and
peptic ulceration. Opiates are the mainstay of analgesic therapy
and should be titrated to effect.
Psychological factors
Psychological support should be offered to all patients following
a burn injury. Repeated visits to the operating theatre and
sedation for dressing changes can be very stressful. Both phar-
macological (i.e. premedication) and non-pharmacological ther-
apies can be used together to allay this. A
FURTHER READING
Allman KG, McIndoe A, Wilson IH, eds. Oxford handbook of anaesthesia.
2nd edn. Oxford: Oxford University Press, 2006.
Hines R, Marschall K, eds. Stoelting’s anesthesia and coexisting disease.
5th edn. Philadelphia: Saunders Elsevier, 2009.
Herndon D. Total burn care. 3rd edn. Philadelphia: Saunders Elsevier,
2007.
Web site: www.totalburncare.com, 2010.
� 2010 Elsevier Ltd. All rights reserved.